These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6161520)

  • 1. [Distribution of various 57Co-labelled zhengguangmycin preparations in Ehrlich carcinoma bearing mice in relation with their antitumor activity and toxicity (author's transl)].
    Xue SB; Liu HT; Zhang HQ; Li DD; Lin HY
    Yao Xue Xue Bao; 1980 Jan; 15(1):1-6. PubMed ID: 6161520
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
    Zimmermann M; Hale T
    Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A preliminary study of 57Ca-zhengguangmycin distribution in tumor-bearing mice and in clinical scanning (author's transl)].
    Liu HT; Xue SB; Zhang HQ; Tang J; Zhang YM; Tian ZJ; Wang JX; Meng FY
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):106-12. PubMed ID: 95441
    [No Abstract]   [Full Text] [Related]  

  • 4. Uptake of labelled tallysomycin by solid Ehrlich ascites tumors in mice.
    Liniecki J; Rembelska M; Koniarek B
    Nuklearmedizin; 1983 Jun; 22(3):159-61. PubMed ID: 6194513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of radiotherapy upon tumor accumulation and organ distribution of 57Co-bleomycin in mice with chemically induced squamous cell carcinoma (author's transl)].
    Pertynski T; Ketkar MB; Mariss P; Reznik G; Hassenstein E; Nüsslin F; Dieffenbach G; Haindl H
    Strahlentherapie; 1979 Nov; 155(11):770-3. PubMed ID: 92831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular transport mechanisms for 57Co-bleomycin].
    Metelmann HR; Bier J; Bitter K
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):99-101. PubMed ID: 6157514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. I. Activity concentrations in transplantable tumours and organs-tissues of mice.
    Rembelska MJ; Liniecki J
    Nuklearmedizin; 1982 Apr; 21(2):62-7. PubMed ID: 6179045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of labeled bleomycin in normal and tumor-bearing mice.
    Grove RB; Eckelman WC; Reba RC
    J Nucl Med; 1973 Dec; 14(12):917-9. PubMed ID: 4127738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Labeling reactions of L-lysine and poly-L-lysine with 57Co and their distribution in normal and Ehrlich ascites tumor-bearing mice (author's transl)].
    Motohashi N; Terao M; Mori I
    Radioisotopes; 1981 Feb; 30(2):80-5. PubMed ID: 6794106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of main fractions of labelled bleomycin by solid Ehrlich ascites tumours in mice.
    Rembelska M; Liniecki J; Koniarek B; Krawczyk Z
    Nuklearmedizin; 1984 Jun; 23(3):127-9. PubMed ID: 6207486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of uptake of 67Ga-citrate and 57Co-bleomycin in tumor using a semiconductor detector.
    Higashi T; Kanno M; Tomura K
    J Nucl Med; 1974 Dec; 15(12):1167-70. PubMed ID: 4139249
    [No Abstract]   [Full Text] [Related]  

  • 12. [A substance with affinity for malignant cancer, 57Co-bleomycin].
    Kono A; Kojima M; Maeda T
    Rinsho Hoshasen; 1973 Mar; 18(3):195-6. PubMed ID: 4122814
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies of 57-co-bleomycin in patients with carcinoma colli uteri (author's transl)].
    Schober O; Mariss P; Pertynski T; Zimmermann P; Börner P
    Rofo; 1978 Jun; 128(6):754-7. PubMed ID: 79534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positive tumor scintigraphy. I. Pharmacokinetics of 111In and 57Co bleomycin].
    Blottner A; Deckart H; Weiland J
    Radiobiol Radiother (Berl); 1978 Jun; 19(3):365-77. PubMed ID: 82976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on antitumor activities of bleomycin oil suspension in vivo (author's transl)].
    Abe F; Ichoda Y; Yamashita T; Yamaguchi S; Yoshioka O
    Jpn J Antibiot; 1976 Sep; 29(9):834-40. PubMed ID: 61292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intratumoral administration of 57Co-bleomycin--results of animal experiment studies and a small pilot study].
    Henke E; Fröhlich M; Gens J; Franke WG; Arnold W
    Radiobiol Radiother (Berl); 1987; 28(2):140-3. PubMed ID: 2443943
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of antitumor agents on carcinoma cells: bleomycin's effects on Ehrlich's carcinoma.
    Sakashita T
    Acta Med Biol (Niigata); 1975 Apr; 22(3-4):143-52. PubMed ID: 53983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies on the uptake and organ distribution of 57Co-bleomycin and 57Co-bleomycin-A2 in mice with squamous cell tumors of the skin and vagina].
    Pertynski T; Ketkar MB; Mariss P; Reznik G; Talas A; Dieffenbach G
    Nuklearmedizin; 1979; 18(6):300-3. PubMed ID: 94162
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracellular distribution of 57Co-bleomycin.
    Konings AW; Rasker JJ; Posthuma GA
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):497-512. PubMed ID: 76527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)].
    Zhou JX; He GH; Tao LX; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.